FDA Announces Final Guidance on Treatment of Partial Onset Seizures in Pediatric Patients

Summary

The FDA has released a final guidance document outlining recommendations for the clinical development of drugs for partial onset seizures in children aged 2 years and older, building on the agency's previous thinking on extrapolating efficacy from adult treatments.